{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:41:43Z","timestamp":1725835303837},"reference-count":11,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T00:00:00Z","timestamp":1182816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold>The hepatitis\u2003C virus antibody (anti\u2010HCV) can be identified with third\u2010generation immunoassays. The purpose of this study was to define the correlation or agreement between first and second reactive results of anti\u2010HCV microparticle\u2010based enzyme immunoassay (MEIA) and of chemiluminescence assays (ChLIAs) in blood donors, to determine whether repeat testing is necessary.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold>Commercially available assays, third\u2010generation HCV MEIA (Abbott), third\u2010generation HCV ChLIA (Ortho), and third\u2010generation HCV ChLIA (Abbott), were used to evaluate anti\u2010HCV repeatedly reactive blood obtained from donations made at 23 Mexican blood centers over a period of 1\u2003year. The intraassay correlation between first and second reactive anti\u2010HCV tests with the Pearson r\u2003test and the coefficient of variation (CV) were determined.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold>The intraassay correlation of 565 anti\u2010HCV repeatedly reactive samples was 0.996 for the Abbott third\u2010generation HCV MEIA, 0.995 for the Ortho third\u2010generation HCV ChLIA, and 0.993 for the Abbott third\u2010generation HCV ChLIA. The CVs of these assay systems were 2.82, 5.33, and 5.69\u2003percent, respectively.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold>A highly significant intraassay correlation between anti\u2010HCV duplicates was found. Specimens with a single reactive anti\u2010HCV result with the Abbott third\u2010generation HCV MEIA, Ortho third\u2010generation HCV ChLIA, and Abbott third\u2010generation HCV ChLIA assays should be considered as positive and need not be retested. Such a change in the algorithm for blood donor screening is feasible because of the availability of highly automated platforms.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2007.01342.x","type":"journal-article","created":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T23:35:20Z","timestamp":1182900920000},"page":"1686-1690","source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis\u2003C antibody intraassay correlation: is retest in duplicate necessary?"],"prefix":"10.1111","volume":"47","author":[{"given":"Ana\u2003M.","family":"Contreras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erendi","family":"Tinoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Celis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Novelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V. Patricia","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etelvina","family":"Carrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Jim\u00e9nez\u2010M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"donHCVir Mexican Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,26]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40010015.x"},{"issue":"3","key":"e_1_2_7_3_2","first-page":"1","article-title":"Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention","volume":"52","author":"Alter MJ","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oso\/9780192617057.001.0001","volume-title":"Principles of exposure measurement in epidemiology","author":"Armstrong BK","year":"1992"},{"volume-title":"Hepatitis C virus encoded antigen (recombinant HCr43, c200, c100\u20103, and NS5) Abbott AxSYM Anti\u2010HCV 3.0 [package insert].","year":"2004","key":"e_1_2_7_5_2"},{"volume-title":"Hepatitis C virus encoded antigen (recombinant c22\u20103, c200, and NS5) Ortho VITROS Anti\u2010HCV 3.0 [package insert].","year":"2003","key":"e_1_2_7_6_2"},{"volume-title":"Hepatitis C virus encoded antigen (recombinant c100\u20103, HCr43, and NS5) Abbott PRISM HCV 3.0 [package insert].","year":"2002","key":"e_1_2_7_7_2"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1373\/49.3.479"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00521.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92054-0"},{"key":"e_1_2_7_11_2","first-page":"854","article-title":"Significance of NS3 and NS5 antigens in screening for HCV antibody","volume":"343","author":"Goffin E","year":"1994","journal-title":"Lancet"},{"key":"e_1_2_7_12_2","unstructured":"2005 annual report [monograph on the Internet]. Abbott Park (IL):Abbott Laboratories[accessed 2007 May 22]. Available from:http:\/\/www.abbott.com\/static\/content\/microsite\/annual_report\/2005\/includes\/abbott_ar05_full.pdf"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2007.01342.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2007.01342.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:49:21Z","timestamp":1708004961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2007.01342.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,26]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1537-2995.2007.01342.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01342.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"type":"print","value":"0041-1132"},{"type":"electronic","value":"1537-2995"}],"subject":[],"published":{"date-parts":[[2007,6,26]]}}}